Hostname: page-component-8448b6f56d-c4f8m Total loading time: 0 Render date: 2024-04-25T02:19:50.074Z Has data issue: false hasContentIssue false

Clinical study of mucosa-associated lymphoid tissue lymphomas of the head and neck

Published online by Cambridge University Press:  26 August 2011

S Hosokawa*
Affiliation:
Department of Otolaryngology, Hamamatsu University School of Medicine, Japan
J Okamura
Affiliation:
Department of Otolaryngology, Hamamatsu University School of Medicine, Japan
Y Takizawa
Affiliation:
Department of Otolaryngology, Hamamatsu University School of Medicine, Japan
G Takahashi
Affiliation:
Department of Otolaryngology, Hamamatsu University School of Medicine, Japan
K Hosokawa
Affiliation:
Department of Otolaryngology, Hamamatsu University School of Medicine, Japan
H Mineta
Affiliation:
Department of Otolaryngology, Hamamatsu University School of Medicine, Japan
*
Address for correspondence: Dr Seiji Hosokawa, Department of Otolaryngology, Hamamatsu University School of Medicine, 1-20-1 Higashi-ku Handayama, Hamamatsu, Shizuoka 431-3192, Japan Fax: +81 53 435 2253 E-mail: seijih@hama-med.ac.jp

Abstract

Background:

Limited information is available on mucosa-associated lymphoid tissue lymphomas arising in the head and neck.

Method:

A retrospective analysis was conducted of 20 patients who were histologically diagnosed with mucosa-associated lymphoid tissue lymphoma and treated at our institution between January 1990 and December 2009.

Results:

Treatment consisted of surgical resection alone in two patients (10 per cent), surgical resection with consecutive radiotherapy in one (5 per cent), and radiotherapy alone in eight (40 per cent). Three patients (15 per cent) were treated with systemic chemotherapy, and three (15 per cent) received chemoradiotherapy. Three patients (15 per cent) were informed of the diagnosis but not treated for their condition.

Conclusion:

All of the 20 patients were still alive after a mean follow-up period of 50.8 months. Local treatment for mucosa-associated lymphoid tissue lymphoma of the head and neck should be the first choice in early-stage disease. However, prolonged follow up is important to determine these patients' long-term response to treatment.

Type
Main Articles
Copyright
Copyright © JLO (1984) Limited 2011

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1Isaacson, P, Wright, DH. Malignant lymphoma of mucosa-associated lymphoid tissue. A distinctive type of B-cell lymphoma. Cancer 1983;52:1410–163.0.CO;2-3>CrossRefGoogle ScholarPubMed
2Gleeson, MJ, Bennett, MH, Cawson, RA. Lymphomas of salivary gland. Cancer 1986;58:6997043.0.CO;2-E>CrossRefGoogle Scholar
3Watkin, GT, MacLennan, KA, Hobsley, M. Lymphomas presenting as lumps in the parotid region. Br J Surg 1984;71:701–2CrossRefGoogle ScholarPubMed
4Yoshino, T, Akagi, T. Gastric low-grade mucosa-associated lymphoid tissue lymphomas: their histogenesis and high-grade transformation. Pathol Int 1998;48:323–31CrossRefGoogle ScholarPubMed
5The International Non Hodgkin's Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med 1993;329:987–94CrossRefGoogle Scholar
6Plosker, GL, Figgitt, DP. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia. Drugs 2003;63:803–43CrossRefGoogle ScholarPubMed
7Zukerberg, LR, Medeiros, LJ, Ferry, JA, Harris, NL. Diffuse low-grade B-cell lymphomas. Four clinically distinct subtypes defined by a combination of morphologic and immunophenotypic features. Am J Clin Pathol 1993;100:373–85CrossRefGoogle ScholarPubMed
8Ando, M, Matsuzaki, M, Murofushi, T. Mucosa-associated lymphoid tissue lymphoma presented as diffuse swelling of the parotid gland. Am J Otolaryngol 2005;26:285–8CrossRefGoogle ScholarPubMed
9Bhattacharyya, N, Frankenthaler, RA, Gomolin, HI, Kadin, ME, Lauretano, A. Clinical and pathologic characterization of mucosa-associated lymphoid tissue lymphoma of the head and neck. Ann Otol Rhinol Laryngol 1998;107:801–6CrossRefGoogle ScholarPubMed
10Vega, F, Lin, P, Medeiros, LJ. Extranodal lymphomas of the head and neck. Ann Diagn Pathol 2005;9:340–50CrossRefGoogle ScholarPubMed
11Suh, C, Huh, J, Roh, JL. Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue arising in the extracranial head and neck region: a high rate of dissemination and disease recurrence. Oral Oncol 2008;44:949–55CrossRefGoogle ScholarPubMed
12Wenzel, C, Fiebiger, W, Dieckmann, K, Formanek, M, Chott, A, Raderer, M. Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue of the head and neck area: high rate of disease recurrence following local therapy. Cancer 2003;97:2236–41CrossRefGoogle ScholarPubMed
13Fisher, RI, Dahlberg, S, Nathwani, BN, Banks, PM, Miller, TP, Grogan, TM. A clinical analysis of two indolent lymphoma entities: mantle cell lymphoma and marginal zone lymphoma (including the mucosa-associated lymphoid tissue and monocytoid B-cell subcategories): a Southwest Oncology Group study. Blood 1995;85:1075–82CrossRefGoogle ScholarPubMed
14Horny, HP, Ferlito, A, Carbone, A. Laryngeal lymphoma derived from mucosa-associated lymphoid tissue. Ann Otol Rhinol Laryngol 1996;105:577–83CrossRefGoogle ScholarPubMed
15Thieblemont, C, Berger, F, Coiffier, B. Mucosa-associated lymphoid tissue lymphomas. Curr Opin Oncol 1995;7:415–20CrossRefGoogle ScholarPubMed
16Jacobs, C, Weiss, L, Hoppe, RT. The management of extranodal head and neck lymphomas. Arch Otolaryngol Head Neck Surg 1986;112:654–8CrossRefGoogle ScholarPubMed
17Zinzani, PL, Magagnoli, M, Galieni, P, Martelli, M, Poletti, V, Zaja, F et al. Nongastrointestinal low-grade mucosa-associated lymphoid tissue lymphoma: analysis of 75 patients. J Clin Oncol 1999;17:1254–8CrossRefGoogle ScholarPubMed